ABVC BioPharma (ABVC) EBITDA (2010 - 2026)
ABVC BioPharma (ABVC) EBITDA from Jun 30, 2010 to Mar 31, 2026. The TTM ABVC BioPharma (ABVC) EBITDA is -$5.71M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
ABVC BioPharma (ABVC) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +239.19% |
| 3 Years TTM | -22.49% |
| 5 Years TTM | -10.10% |
| 10 Years TTM | +44.10% |
| All Time TTM | +14.18% |
Annual EBITDA change of ABVC BioPharma (ABVC)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$1.57M | -77.98% |
| 2025 | -$7.13M | +52.68% |
| 2024 | -$4.67M | -30.71% |
| 2023 | -$6.74M | -55.33% |
| 2022 | -$15M | +29.08% |
| 2021 | -$12M | +38.02% |
| 2020 | -$8.47M | +149.12% |
| 2019 | -$3.40M | +24.09% |
| 2018 | -$2.74M | +682.86% |
| 2017 | -$350K | +66.67% |
| 2016 | -$210K | +600.00% |
| 2015 | -$30K | N/A |
| 2014 | $0 | -100.00% |
| 2013 | -$150K | -86.49% |
| 2012 | -$1.11M | -40.00% |
| 2011 | -$1.85M | +0.54% |
| 2010 | -$1.84M | N/A |
Comparison ABVC BioPharma (ABVC) five years EBITDA CAGR with competitors
ABVC BioPharma (ABVC) five years EBITDA CAGR is -7.60%.